Reply to M.C. Chamberlain and C. Gemici

Comment

Riccardo Soffietti. J Clin Oncol. 2013.

. 2013 Jul 10;31(20):2636-7.

doi: 10.1200/JCO.2013.49.4443.

No abstract available

Comment on

A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A. Soffietti R, et al. J Clin Oncol. 2013 Jan 1;31(1):65-72. doi: 10.1200/JCO.2011.41.0639. Epub 2012 Dec 3. J Clin Oncol. 2013. PMID: 23213105 Clinical Trial.
Does quality of life supplant survival in patients with brain metastasis?
Chamberlain MC. Chamberlain MC. J Clin Oncol. 2013 Jul 10;31(20):2635. doi: 10.1200/JCO.2013.48.9286. Epub 2013 Jun 3. J Clin Oncol. 2013. PMID: 23733762 No abstract available.
Progression-free survival benefit or health-related quality-of-life advantage: which one to choose?
Gemici C. Gemici C. J Clin Oncol. 2013 Jul 10;31(20):2635-6. doi: 10.1200/JCO.2013.49.3478. Epub 2013 Jun 3. J Clin Oncol. 2013. PMID: 23733775 No abstract available.